CervoMed Inc. (CRVO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $25.26M
Last updated: Nov 17, 2026 at 4:42 PM ET
CervoMed Inc. (CRVO) Statistics
CervoMed (CRVO) has a market cap of $25.26M and an enterprise value of $19.20M. It kept -326822.54% of revenue as net income over the last 12 months. Its share count is up 63.40% from a year earlier.
Total Valuation
Enterprise value is 23.99% below the market cap, as cash exceeds debt.
| Market Cap | $25.26M |
|---|---|
| Enterprise Value | $19.20M |
| Latest price (Nov 17, 2026) | $1.50 |
Key Dates
The next earnings report is expected on Mar 11, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 11, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 6, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 80.47% over 52 weeks and trades 34.78% below its 50-day average.
| Beta (1Y) | 2.20 |
|---|---|
| 52-Week Change | -80.47% |
| 1-Month Change | -35.06% |
| 3-Month Change | -44.65% |
| 6-Month Change | -48.10% |
| 5-Year Change | -95.30% |
| 10-Year Change | -99.96% |
| Total Return (1Y) | -80.47% |
| Total Return (3Y CAGR) | -46.63% |
| Total Return (5Y CAGR) | -45.13% |
| Return vs SPY (1Y) | -93.49% |
| Max Drawdown (1Y) | -86.22% |
| Max Drawdown (3Y) | -94.72% |
| Sharpe Ratio (1Y) | -1.58 |
| Correlation with SPY (1Y) | 0.28 |
| 50-Day Average | $2.30 |
| 200-Day Average | $3.24 |
| 52-Week Range | $1.27 to $10.00 |
| RSI (14 Days) | 35.3 |
| Average Volume (20 Days) | 983.26K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 5.37x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 5.37x |
|---|---|
| Quick Ratio | 5.37x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -164.32% and return on assets is -133.70% over the last 12 months.
| Return on Equity (ROE) | -164.32% |
|---|---|
| Return on Assets (ROA) | -133.70% |
| ROA (5Y Average) | -76.14% |
| Asset Turnover | 0.00x |
Scores
CRVO has an Altman Z-Score of -7.87, in the distress zone below 1.81, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -7.87 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 1 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue of $8.73K over the last 12 months is down 99.86% from the 12 months before.
| Revenue | $8.73K |
|---|---|
| Revenue Growth (YoY) | -99.86% |
| Gross Profit | $8.73K |
| Operating Income | -$29.23M |
| Pretax Income | -$28.52M |
| Net Income | -$28.52M |
| Reported EPS (TTM) | -$2.77 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 81.39% of the $21.33M in total assets.
| Cash and Equivalents | $6.06M |
|---|---|
| Total Debt | $0 |
| Net Cash | $6.06M |
| Net Cash Per Share | $0.40 |
| Working Capital | $17.36M |
| Shareholder Equity | $17.36M |
| Book Value Per Share | $1.15 |
| Total Assets | $21.33M |
| Total Liabilities | $3.97M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$26.59M |
|---|---|
| FCF Per Share | -$1.76 |
| Depreciation and Amortization | $345.48K |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -334924.87%.
| Gross Margin | 100.00% |
|---|---|
| Operating Margin | -334924.87% |
| Pretax Margin | -326822.54% |
| Net Margin | -326822.54% |
Growth
| Book Value Per Share Growth (2Y CAGR) | +23.09% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | +23.09% |
Dividends and Yields
CRVO does not pay a dividend.
| Buyback Yield | 1.59% |
|---|---|
| Shareholder Yield | 1.59% |
Stock Splits
The last reverse split was on Aug 17, 2023.
| Last Split Date | Aug 17, 2023 |
|---|---|
| Split Type | Reverse split |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About CRVO
What is CRVO's market cap?
CervoMed has a market cap of $25.26M. Its enterprise value, which adds debt and subtracts cash, is $19.20M.
How many shares of CRVO are outstanding?
CervoMed has 15.12M shares outstanding. The count is up 63.40% from a year earlier.
Does CRVO pay a dividend?
No. CervoMed does not pay a dividend.
How much debt does CRVO have?
CervoMed has $0 of total debt and $6.06M of cash and equivalents, a net cash position of $6.06M.
CRVO pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors